Cancer gene therapy by direct tumor injections of a nonviral T7 vector encoding a thymidine kinase gene.

Abstract:

:Previously, we described a nonviral cytoplasmic gene therapy vector system based on the T7 autogene concept. This system has been shown to achieve rapid and high levels of gene expression in a variety of animal cells and tissues. To test the utility of the system in vivo tumor ablation, a T7 cancer gene therapy plasmid vector, pT7T7/T7TK, was constructed. This nonviral vector contains a T7 autogene, T7T7, and a human herpes simplex virus thymidine kinase (HSV-TK) gene driven by a second T7 promoter (T7TK). When co-transfected with T7 RNA polymerase (T7 RNAP) into cultured human osteosarcoma 143B cells, abut 10-20% of the cells were found to express HSV-TK, and more than 90% of the cells were killed in the presence of 1 microM ganciclovir (GCV) within 4 days after DNA transfection. The increase in killing above the transfection frequency is due to a "bystander" effect among transfected and untransfected 143B cells. Direct injections of pT7T7/T7TK into 143B tumors grown in nude mice resulted in TK gene expression in tumor cells located near the injection sites as revealed by the immunohistochemical staining. Repeated tumor injections of the pT7T7/T7TK vector and intraperitoneal (i.p.) injections of GCV resulted in inhibition of tumor growth and in tumor shrinkage in 6 out of 10 treated nude mice. Three of those six tumors fully regressed shortly after the end of the GCV injections. All of the full tumor regressions were found to be permanent and no apparent tumor relapses were observed for the rest of the lives of the treated nude mice after the initial tumor ablations. These results, combined with the nonviral and rapid cytoplasmic gene expression features, suggest that the T7 vector may be a good candidate for cancer gene therapy and other medical and biological applications.

journal_name

Hum Gene Ther

journal_title

Human gene therapy

authors

Chen X,Li Y,Xiong K,Aizicovici S,Xie Y,Zhu Q,Sturtz F,Shulok J,Snodgrass R,Wagner TE,Platika D

doi

10.1089/hum.1998.9.5-729

subject

Has Abstract

pub_date

1998-03-20 00:00:00

pages

729-36

issue

5

eissn

1043-0342

issn

1557-7422

journal_volume

9

pub_type

杂志文章
  • Capsid-modified adenoviral vectors for improved muscle-directed gene therapy.

    abstract::Skeletal muscle represents an attractive target tissue for adenoviral gene therapy to treat muscle disorders and as a production platform for systemic expression of therapeutic proteins. However, adenovirus serotype 5 vectors do not efficiently transduce adult muscle tissue. Here we evaluated whether capsid modificati...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2012.003

    authors: Guse K,Suzuki M,Sule G,Bertin TK,Tyynismaa H,Ahola-Erkkilä S,Palmer D,Suomalainen A,Ng P,Cerullo V,Hemminki A,Lee B

    更新日期:2012-10-01 00:00:00

  • Antigen-specific tolerance of human alpha1-antitrypsin induced by helper-dependent adenovirus.

    abstract::As efficient and less toxic virus-derived gene therapy vectors are developed, a pressing problem is to avoid immune response to the therapeutic gene product. Secreted therapeutic proteins potentially represent a special problem, as they are readily available to professional antigen-presenting cells throughout the body...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2006.036

    authors: Cerullo V,McCormack W,Seiler M,Mane V,Cela R,Clarke C,Rodgers JR,Lee B

    更新日期:2007-12-01 00:00:00

  • Novel SRESPHP peptide mediates specific binding to primary medullary thyroid carcinoma after systemic injection.

    abstract::The efficient and specific introduction of genes into cancer cells in vivo remains a major challenge for current gene therapy modalities. Peptides possess appropriate properties to serve as tumor-targeting agents. Thus, finding new cancer-selective peptides directing gene transfer to neoplastic cells by reducing trans...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2005.16.1267

    authors: Böckmann M,Hilken G,Schmidt A,Cranston AN,Tannapfel A,Drosten M,Frilling A,Ponder BA,Pützer BM

    更新日期:2005-11-01 00:00:00

  • Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo.

    abstract::Engineering gene therapy vectors to modulate the immune response is an important goal. In this regard, costimulation of T cells is a critical determinant in immune activation. The costimulatory molecule CD40, expressed on antigen-presenting cells, is thought to interact with CD40 ligand (CD40L) expressed on activated ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303401750214302

    authors: Sin JI,Kim JJ,Zhang D,Weiner DB

    更新日期:2001-06-10 00:00:00

  • In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors.

    abstract::Tumor angiogenesis is a rate-limiting factor for tumor growth, and the endothelial cells of tumor vessels display specific features that can be exploited for the selective delivery of cancer therapeutics. To specifically target exogenous genes to angiogenic tumor vessels, we generated a panel of vesicular stomatitis v...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303403322168028

    authors: De Palma M,Venneri MA,Naldini L

    更新日期:2003-08-10 00:00:00

  • Transient transfection methods for clinical adeno-associated viral vector production.

    abstract::Recombinant adeno-associated virus (AAV)-based vectors expressing therapeutic gene products have shown great potential for human gene therapy. One major challenge for translation of promising research to clinical development is the manufacture of sufficient quantities of AAV vectors that meet stringent standards for p...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2009.064

    authors: Wright JF

    更新日期:2009-07-01 00:00:00

  • Increased transduction of skeletal muscle cells by fibroblast growth factor-modified adenoviral vectors.

    abstract::Gene therapy for Duchenne muscular dystrophy will likely require that the corrective dystrophin gene be delivered to a high fraction of muscle fibers in vivo. Because of the large size of the dystrophin cDNA, adenoviral (Ad) vectors have been developed for this application. However, Ad vectors transduce mature muscle ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2006.17.314

    authors: Menezes KM,Mok HS,Barry MA

    更新日期:2006-03-01 00:00:00

  • lacZ transgenic rats tolerant for beta-galactosidase: recipients for gene transfer studies using lacZ as a reporter gene.

    abstract::Gene transfer of reporter genes may trigger immune responses against the heterologous protein resulting in shortening of gene expression and inflammation. We generated transgenic rats expressing the lacZ gene under the control of the human immunodeficiency virus type 1 (HIV-1) long-terminal repeat (LTR) (HIV-lacZ) to ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303402760128603

    authors: Ménoret S,Aubert D,Tesson L,Braudeau C,Pichard V,Ferry N,Anegon I

    更新日期:2002-07-20 00:00:00

  • ssDNA and the Argonautes: The Quest for the Next Golden Editor.

    abstract::Genome engineering has gone mainstream because of breakthroughs in defining and harnessing naturally occurring, customizable DNA recognition cursors (protein or RNA-guided). At present, most gene editing relies on these cursors to direct custom DNA endonucleases to a specific genomic sequence to induce a double-strand...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2016.071

    authors: Martínez-Gálvez G,Ata H,Campbell JM,Ekker SC

    更新日期:2016-06-01 00:00:00

  • Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery?

    abstract::Systemic administration of currently manufactured viral stocks has not so far achieved sufficient circulating titers to allow therapeutic targeting of metastatic disease. This is due to low initial viral titers, immune inactivation, nonspecific adhesion, and loss of particles. One way to exploit the elegant molecular ...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/104303402760128504

    authors: Harrington K,Alvarez-Vallina L,Crittenden M,Gough M,Chong H,Diaz RM,Vassaux G,Lemoine N,Vile R

    更新日期:2002-07-20 00:00:00

  • Upregulation of Bag-1 by ex vivo gene transfer protects rat livers from ischemia/reperfusion injury.

    abstract::Bag-1 exerts powerful antiapoptotic effects by binding and stabilizing Bcl-2 and interacting with the tumor necrosis factor receptor type I-induced death signal. We examined the effects of overexpression of Bag-1 by ex vivo adenoviral gene transfer on cold (4 degrees C for 24 hr) ischemia/reperfusion (I/R) injury of r...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340260185120

    authors: Sawitzki B,Amersi F,Ritter T,Fisser M,Shen XD,Ke B,Busuttil R,Volk HD,Kupiec-Weglinski JW

    更新日期:2002-08-10 00:00:00

  • Thymidine kinase gene modified bone marrow mesenchymal stem cells as vehicles for antitumor therapy.

    abstract::Bone marrow mesenchymal stem cells (BMSCs) represent an important source of cells for tissue repair. The tropism of these cells to the sites of injury and tumors has been well established. Their tumor-homing properties make BMSCs good candidates as antitumor agent delivery vehicles. In this study, we showed that BMSCs...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2010.116

    authors: Song C,Xiang J,Tang J,Hirst DG,Zhou J,Chan KM,Li G

    更新日期:2011-04-01 00:00:00

  • Real-time quantitative polymerase chain reaction to assess gene transfer.

    abstract::Accurate quantification of gene transfer (or gene correction) is a universal challenge in the field of gene therapy. In developing a clinical trial of lymphocyte gene therapy for Hunter syndrome (mucopolysaccharidosis type II), methods using Southern blot or automated DNA sequencing technology were employed, but found...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950016898

    authors: Becker K,Pan D,Whitley CB

    更新日期:1999-10-10 00:00:00

  • Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.

    abstract::Subcutaneous vaccination therapy with glioma cells, which are retrovirally transduced to secrete granulocyte-macrophage colony-stimulating factor (GM-CSF), has previously proven effective in C57BL/6 mice harboring intracerebral GL261 gliomas. However, clinical ex vivo gene therapy for human gliomas would be difficult,...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340050057503

    authors: Herrlinger U,Jacobs A,Quinones A,Woiciechowsky C,Sena-Esteves M,Rainov NG,Fraefel C,Breakefield XO

    更新日期:2000-07-01 00:00:00

  • Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain.

    abstract::RNA interference (RNAi) is an evolutionarily conserved mechanism of posttranscriptional gene-specific silencing. For in vivo applications, RNAi has been hampered until recently by inefficient delivery methods and by the transient nature of the gene suppression. Lentiviral vectors (LVs) hold great promise for gene ther...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303403322611809

    authors: Van den Haute C,Eggermont K,Nuttin B,Debyser Z,Baekelandt V

    更新日期:2003-12-10 00:00:00

  • The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope.

    abstract::The immunogenicity of adenovirus vectors remains a major obstacle to their safe and efficacious use for gene therapy. In order to identify T-cell epitopes directly from adenoviruses, four viral protein sequences were screened for the well-characterized 9-mer HLA-A2 binding motif. Peripheral blood mononuclear cells (PB...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303402320138952

    authors: Olive M,Eisenlohr L,Flomenberg N,Hsu S,Flomenberg P

    更新日期:2002-07-01 00:00:00

  • Evaluation of PCR and ELISA assays for screening clinical trial subjects for replication-competent retrovirus.

    abstract::Gene delivery via murine-based recombinant retroviral vectors is currently widely used in gene therapy clinical trials. The vectors are engineered to be replication defective by replacing the structural and nonstructural genes of a cloned infectious retrovirus with a therapeutic gene of interest. The retroviral partic...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1997.8.10-1231

    authors: Martineau D,Klump WM,McCormack JE,DePolo NJ,Kamantigue E,Petrowski M,Hanlon J,Jolly DJ,Mento SJ,Sajjadi N

    更新日期:1997-07-01 00:00:00

  • Nuclease-deficient CRISPR-based approaches for in vitro and in vivo gene activation.

    abstract::CRISPR-based technology has been adapted to achieve a wide range of genome modifications including transcription regulation. The focus of this review is on the application of CRISPR-based platforms such as nuclease-deficient Cas9 and Cas12a, to achieve targeted gene activation. We review studies to date that have empl...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2020.241

    authors: Lek A,Ma K,Woodman K,Lek M

    更新日期:2021-01-15 00:00:00

  • Antisense oligonucleotides for the treatment of spinal muscular atrophy.

    abstract::Spinal muscular atrophy (SMA) is an autosomal recessive disease affecting ∼1 in 10,000 live births. The most striking component is the loss of α-motor neurons in the ventral horn of the spinal cord, resulting in progressive paralysis and eventually premature death. There is no current treatment paradigm other than sup...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2012.225

    authors: Porensky PN,Burghes AH

    更新日期:2013-05-01 00:00:00

  • Silencing of GAS5 Alleviates Glaucoma in Rat Models by Reducing Retinal Ganglion Cell Apoptosis.

    abstract::Retinal ganglion cells (RGCs) play a key role in the pathogenesis and development of glaucoma. The present study aims to investigate the underlying mechanism of long noncoding RNA growth arrest-specific transcript 5 (GAS5) in glaucoma development through regulating the apoptosis of RGCs. Rat models of chronic glaucoma...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2019.056

    authors: Zhou RR,Li HB,You QS,Rong R,You ML,Xiong K,Huang JF,Xia XB,Ji D

    更新日期:2019-12-01 00:00:00

  • Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.

    abstract::Unlike oncoretroviruses, lentiviral vectors can insert large genes and can target both dividing and nondividing cells; thus they hold unique promise as gene transfer agents. To enhance target range, the native lentiviral envelope glycoprotein is replaced (pseudotyped) with vesicular stomatitis virus G (VSVG), and the ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340360464723

    authors: Kumar M,Bradow BP,Zimmerberg J

    更新日期:2003-01-01 00:00:00

  • Retrovirus-mediated transfer of anti-MDR1 ribozymes fully restores chemosensitivity of P-glycoprotein-expressing human lymphoma cells.

    abstract::Development of multidrug resistance (MDR) is the major obstacle to successful cancer chemotherapy. We have developed Daudi human lymphoma cells that are 20-fold more resistant than the parent cell line to vincristine (VCR) by infecting cells with pHaMDR1/A retroviral vector (Daudi/MDR20). Three DNA sequences of anti-M...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950018175

    authors: Wang FS,Kobayashi H,Liang KW,Holland JF,Ohnuma T

    更新日期:1999-05-01 00:00:00

  • Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, nonconcentrated vector-containing medium.

    abstract::Defined serum-free conditions have great conceptual advantages for the biological safety and standardization of clinical gene transfer into hematopoietic stem cells. In the only study reported to date, Sekhar et al. achieved low serum conditions by a complex concentration procedure of a retroviral supernatant initiall...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.6-771

    authors: Glimm H,Flügge K,Möbest D,Hofmann VM,Postmus J,Henschler R,Lange W,Finke J,Kiem HP,Schulz G,Rosenthal F,Mertelsmann R,von Kalle C

    更新日期:1998-04-10 00:00:00

  • Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands.

    abstract::Although replication-deficient adenoviruses can efficiently transfer genes to the salivary glands, the current vectors precipitate an immediate, transient decrease in salivary function. To study the cause of this salivary hypofunction, 10(6)-10(10) plaque-forming units (pfu) of the vector AdCMV beta gal were delivered...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1996.7.9-1085

    authors: Adesanya MR,Redman RS,Baum BJ,O'Connell BC

    更新日期:1996-06-10 00:00:00

  • Augmentation of antitumor activity of a recombinant adeno-associated virus carcinoembryonic antigen vaccine with plasmid adjuvant.

    abstract::Recombinant adeno-associated virus 2 (rAAV) vectors have been successfully used for sustained expression of therapeutic genes. The potential of using rAAV as a cancer vaccine vector and the impact of a bacterial plasmid adjuvant on this activity were investigated. C57BL/6 mice received a single intramuscular injection...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2004.15.856

    authors: Ponnazhagan S,Mahendra G,Lima J,Aldrich WA,Jenkins CB,Ren C,Kumar S,Kallman L,Strong TV,Shaw DR,Triozzi PL

    更新日期:2004-09-01 00:00:00

  • Highly efficient adenovirus-mediated gene transfer to cardiac myocytes after single-pass coronary delivery.

    abstract::Efficient and homogeneous gene transfer to cardiac myocytes is a major target in myocardial gene therapy. The aim of this study was to determine the conditions permitting efficient, homogeneous, adenovirus-mediated gene transfer to cardiac myocytes, with a view to application during coronary artery catheterization. Ge...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340050015329

    authors: Logeart D,Hatem SN,Rücker-Martin C,Chossat N,Névo N,Haddada H,Heimburger M,Perricaudet M,Mercadier JJ

    更新日期:2000-05-01 00:00:00

  • Constraints on Human CD34+ Cell Fate due to Lentiviral Vectors Can Be Relieved by Valproic Acid.

    abstract::The initial stages following the in vitro cytokine stimulation of human cord blood CD34+ cells overlap with the period when lentiviral gene transfer is typically performed. Single-cell transcriptional profiling and time-lapse microscopy were used to investigate how the vector-cell crosstalk impacts on the fate decisio...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2019.009

    authors: Moussy A,Papili Gao N,Corre G,Poletti V,Majdoul S,Fenard D,Gunawan R,Stockholm D,Páldi A

    更新日期:2019-08-01 00:00:00

  • Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes.

    abstract::Introduction of a new vaccine requires choosing a delivery system that provides safe administration and the desired level of immunogenicity. The safety, tolerability, and immunogenicity of three monthly 2.5-mg doses of a PfCSP DNA vaccine were evaluated in healthy volunteers as administered intramuscularly (IM) by nee...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340260201644

    authors: Epstein JE,Gorak EJ,Charoenvit Y,Wang R,Freydberg N,Osinowo O,Richie TL,Stoltz EL,Trespalacios F,Nerges J,Ng J,Fallarme-Majam V,Abot E,Goh L,Parker S,Kumar S,Hedstrom RC,Norman J,Stout R,Hoffman SL

    更新日期:2002-09-01 00:00:00

  • Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a "modified" step-filtration process for clearance of packaging cells.

    abstract::Production of clinical-grade gammaretroviral vectors for ex vivo gene delivery requires a scalable process that can rapidly generate large amounts of vector supernatant, clear large numbers of residual packaging cells with minimal decreases in vector titer, and satisfy all current regulatory guidelines regarding produ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2010.064

    authors: Feldman SA,Goff SL,Xu H,Black MA,Kochenderfer JN,Johnson LA,Yang JC,Wang Q,Parkhurst MR,Cross S,Morgan RA,Cornetta K,Rosenberg SA

    更新日期:2011-01-01 00:00:00

  • A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors.

    abstract::The efficiency of gene therapy strategies against cancer is limited by the poor distribution of the vectors in the malignant tissues. To solve this problem, a new generation of tumor-specific, conditionally replicative adenoviruses is being developed. To direct the replication of the virus to breast cancer, we have co...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340050143435

    authors: Hernandez-Alcoceba R,Pihalja M,Wicha MS,Clarke MF

    更新日期:2000-09-20 00:00:00